acetic acid has been researched along with Liver Neoplasms in 72 studies
Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this prospective study was to compare the efficacy of percutaneous acetic acid (PAAI) to that of radiofrequency ablation (RFA) in the treatment of small (≤5cm) hepatocellular carcinoma (HCC) using a randomized trial." | 9.34 | Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial. ( Acharya, SK; Gamanagatti, SR; Gulati, MS; Paul, SB; Shalimar, S; Sreenivas, V, 2020) |
| "To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center." | 9.11 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "The aim of this study was to compare the outcomes of radiofrequency thermal ablation (RFTA), percutaneous ethanol injection (PEI), and percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)." | 9.11 | Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. ( Chen, YC; Hsu, CW; Lin, CC; Lin, CJ; Lin, SM, 2005) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective loco-regional therapies for hepatocellular carcinoma (HCC)." | 9.11 | Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. ( Chang, FY; Chiang, JH; Huang, YH; Huo, T; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)." | 9.10 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective treatments for hepatocellular carcinoma (HCC)." | 9.10 | Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. ( Chang, FY; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "To assess the efficacy of ultrasound-guided percutaneous acetic acid (15%, 20%, 30%, 40%, and 50% in concentration) injection for a large nodular hepatocellular carcinoma (HCC), percutaneous acetic acid injection was performed using 15% to 50% acetic acid in 28 patients who had one single nodular HCC larger than 3 cm or one main tumor with fewer than two HCCs smaller than 3 cm during the past 7." | 9.08 | Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996) |
| "To assess the efficacy of ultrasound (US)-guided percutaneous acetic acid (in concentrations of 15%, 20%, 30%, 40%, and 50%) injection for small hepatocellular carcinomas (HCCs) for long-term prognosis, percutaneous acetic acid injection using 15% to 50% acetic acid was performed in 91 patients with one to four HCCs smaller than 3 cm during the past 6." | 9.08 | Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. ( Fujiwara, K; Ito, S; Nomura, F; Ohnishi, K, 1996) |
| "To assess whether ultrasound-guided percutaneous acetic acid injection is superior to percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC), 60 patients with one to four HCCs smaller than 3 cm were entered onto a randomized controlled trial." | 9.08 | Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1998) |
| "To assess whether ultrasound (US)-guided percutaneous acetic acid injection is more effective than percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC)." | 9.08 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Ohnishi, K, 1998) |
| "To assess the efficacy of ultrasound-guided percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)." | 9.07 | Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. ( Fujiwara, K; Ito, S; Ohnishi, K; Ohyama, N, 1994) |
| "3-O-EZ and ingenol can relieve hepatic and gastrointestinal injuries, reduce ascites volumes, enhance the H22 cells apoptosis, ameliorate abnormal pro-inflammatory cytokines and RAAS levels, and down-regulate the expression of AQP8, AQP2, V2R." | 8.02 | The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021) |
| "To evaluate the long-term outcome of CT-guided single high-dose percutaneous acetic acid injection (PAI) for the treatment of small hepatocellular carcinoma (SHCC)." | 7.78 | CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study. ( Liu, F; Liu, J; Ma, H, 2012) |
| "The long-term outcome of percutaneous acetic acid injection (PAI) and percutaneous ethanol injection (PEI) for treating small hepatocellular carcinoma (HCC) remains unclear." | 7.74 | Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study. ( Chan, HH; Chen, TA; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Li, WL; Liang, HL; Lin, CK; Lin, CP; Lo, GH; Tsai, WL; Yu, HC, 2008) |
| "Ultrasound-guided percutaneous acetic acid injection (PAI) therapy is effective for hepatocellular carcinoma (HCC)." | 7.73 | Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis. ( Chang, FY; Huang, HC; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2006) |
| "The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma." | 7.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
| "Monitoring acetic acid distribution on CT fluoroscopy can detect extratumoral diffusion and may optimize the distribution of acetic acid in hepatocellular carcinoma." | 7.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
| "Ultrasound (US)-guided percutaneous acetic acid injection therapy (PAIT) is effective for patients with hepatocellular carcinoma (HCC)." | 7.72 | Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "To evaluate the safety and efficacy of single high-dose percutaneous acetic acid injection (PAI) for treatment of small (<3-cm-diameter) hepatocellular carcinoma (HCC)." | 7.70 | Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000) |
| "Percutaneous acetic acid injection is superior to segmental transcatheter arterial embolization in the treatment of hypervascular small hepatocellular carcinoma." | 7.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "To compare the efficacy of ultrasound-guided percutaneous acetic acid injection and segmental transcatheter arterial embolization for hypervascular small hepatocellular carcinoma." | 7.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "The prognosis of 40 patients with one to three angiographically hypervascular hepatocellular carcinoma smaller than 3 cm in diameter treated with either percutaneous acetic acid injection (25 patients) or transcatheter arterial embolization (15 patients) during the past 4." | 7.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000." | 6.71 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "The 1-, 2- and 3-year recurrence rate from the original main tumor was 0%, 20%, and 20%, respectively, in patients treated with percutaneous acetic acid injection alone and 12%, 24%, and 24% in patients treated with percutaneous acetic acid injection after transcatheter arterial embolization (P = NS)." | 6.68 | Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996) |
| "The H22 mouse hepatoma ascites model was replicated, and were given 3-O-EZ and ingenol seven days (110." | 5.62 | The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021) |
| "Despite the increasing incidence of hepatocellular carcinoma (HCC) worldwide, current pharmacological treatments are still unsatisfactory." | 5.62 | Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth. ( Altomare, A; Cavalluzzi, MM; Gnocchi, D; Lentini, G; Mangiatordi, GF; Mazzocca, A; Rizzi, R; Sabbà, C; Spennacchio, M; Tortorella, C, 2021) |
| "The purpose of this prospective study was to compare the efficacy of percutaneous acetic acid (PAAI) to that of radiofrequency ablation (RFA) in the treatment of small (≤5cm) hepatocellular carcinoma (HCC) using a randomized trial." | 5.34 | Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial. ( Acharya, SK; Gamanagatti, SR; Gulati, MS; Paul, SB; Shalimar, S; Sreenivas, V, 2020) |
| "Single high-dose PAI is safe and effective for treatment of small HCC." | 5.31 | Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective locoregional therapies for hepatocellular carcinoma (HCC)." | 5.11 | Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective loco-regional therapies for hepatocellular carcinoma (HCC)." | 5.11 | Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey. ( Chang, FY; Chiang, JH; Huang, YH; Huo, T; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "The aim of this study was to compare the outcomes of radiofrequency thermal ablation (RFTA), percutaneous ethanol injection (PEI), and percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)." | 5.11 | Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. ( Chen, YC; Hsu, CW; Lin, CC; Lin, CJ; Lin, SM, 2005) |
| "To determine the feasibility and the long-term results of the acetic acid percutaneous injection under CT fluoroscopy guidance in a series of cirrhotic patients with small hepatocellular carcinoma in a single French center." | 5.11 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "Ultrasound-guided percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) are effective in the treatment of hepatocellular carcinoma (HCC)." | 5.10 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "Transarterial chemoembolization (TACE) and percutaneous acetic acid injection (PAI) are effective treatments for hepatocellular carcinoma (HCC)." | 5.10 | Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. ( Chang, FY; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2003) |
| "To assess the efficacy of ultrasound (US)-guided percutaneous acetic acid (in concentrations of 15%, 20%, 30%, 40%, and 50%) injection for small hepatocellular carcinomas (HCCs) for long-term prognosis, percutaneous acetic acid injection using 15% to 50% acetic acid was performed in 91 patients with one to four HCCs smaller than 3 cm during the past 6." | 5.08 | Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. ( Fujiwara, K; Ito, S; Nomura, F; Ohnishi, K, 1996) |
| "To assess whether ultrasound-guided percutaneous acetic acid injection is superior to percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC), 60 patients with one to four HCCs smaller than 3 cm were entered onto a randomized controlled trial." | 5.08 | Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1998) |
| "To assess the efficacy of ultrasound-guided percutaneous acetic acid (15%, 20%, 30%, 40%, and 50% in concentration) injection for a large nodular hepatocellular carcinoma (HCC), percutaneous acetic acid injection was performed using 15% to 50% acetic acid in 28 patients who had one single nodular HCC larger than 3 cm or one main tumor with fewer than two HCCs smaller than 3 cm during the past 7." | 5.08 | Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996) |
| "To assess whether ultrasound (US)-guided percutaneous acetic acid injection is more effective than percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC)." | 5.08 | Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. ( Ohnishi, K, 1998) |
| "To assess the efficacy of ultrasound-guided percutaneous acetic acid injection (PAI) in the treatment of hepatocellular carcinoma (HCC)." | 5.07 | Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. ( Fujiwara, K; Ito, S; Ohnishi, K; Ohyama, N, 1994) |
| " Keywords were Hepatocellular carcinoma, liver metastases, percutaneous ethanol injection, cryotherapy, microwave coagulation therapy, radiofrequency ablation, interstitial laser photocoagulation, focused high-intensity ultrasound, hot saline injection, electrolysis and acetic acid injection." | 4.82 | The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. ( Aylott, C; Berry, DP; Garcea, G; Lloyd, TD; Maddern, G, 2003) |
| "3-O-EZ and ingenol can relieve hepatic and gastrointestinal injuries, reduce ascites volumes, enhance the H22 cells apoptosis, ameliorate abnormal pro-inflammatory cytokines and RAAS levels, and down-regulate the expression of AQP8, AQP2, V2R." | 4.02 | The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021) |
| "To evaluate the long-term outcome of CT-guided single high-dose percutaneous acetic acid injection (PAI) for the treatment of small hepatocellular carcinoma (SHCC)." | 3.78 | CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study. ( Liu, F; Liu, J; Ma, H, 2012) |
| "We investigated the effect of acetic acid (AcOH) on the prevention of obesity in high-fat-fed mice." | 3.75 | Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. ( Fushimi, T; Kaga, T; Kishi, M; Kondo, T, 2009) |
| "The long-term outcome of percutaneous acetic acid injection (PAI) and percutaneous ethanol injection (PEI) for treating small hepatocellular carcinoma (HCC) remains unclear." | 3.74 | Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study. ( Chan, HH; Chen, TA; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Li, WL; Liang, HL; Lin, CK; Lin, CP; Lo, GH; Tsai, WL; Yu, HC, 2008) |
| "Ultrasound-guided percutaneous acetic acid injection (PAI) therapy is effective for hepatocellular carcinoma (HCC)." | 3.73 | Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis. ( Chang, FY; Huang, HC; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2006) |
| "Monitoring acetic acid distribution on CT fluoroscopy can detect extratumoral diffusion and may optimize the distribution of acetic acid in hepatocellular carcinoma." | 3.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
| "Percutaneous injection therapy using acetic acid or pure ethanol is effective for hepatocellular carcinoma (HCC)." | 3.72 | Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "Ultrasound (US)-guided percutaneous acetic acid injection therapy (PAIT) is effective for patients with hepatocellular carcinoma (HCC)." | 3.72 | Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection. ( Chang, FY; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2004) |
| "The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma." | 3.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
| "To evaluate the safety and efficacy of single high-dose percutaneous acetic acid injection (PAI) for treatment of small (<3-cm-diameter) hepatocellular carcinoma (HCC)." | 3.70 | Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000) |
| "To compare the efficacy of ultrasound-guided percutaneous acetic acid injection and segmental transcatheter arterial embolization for hypervascular small hepatocellular carcinoma." | 3.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "The prognosis of 40 patients with one to three angiographically hypervascular hepatocellular carcinoma smaller than 3 cm in diameter treated with either percutaneous acetic acid injection (25 patients) or transcatheter arterial embolization (15 patients) during the past 4." | 3.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "Percutaneous acetic acid injection is superior to segmental transcatheter arterial embolization in the treatment of hypervascular small hepatocellular carcinoma." | 3.69 | Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. ( Fujiwara, K; Ito, S; Kameda, C; Kosaka, K; Nishiyama, J; Ohnishi, K; Toshima, K; Yoshioka, H, 1996) |
| "One hundred and two patients with hepatocellular carcinoma were evaluated for treatment between 1999 and 2000." | 2.71 | Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection. ( Andreani, T; Arrive, L; Chazouillères, O; Fartoux, L; Poupon, R; Rosmorduc, O; Serfaty, L; Tubiana, JM, 2005) |
| "The 1-, 2- and 3-year recurrence rate from the original main tumor was 0%, 20%, and 20%, respectively, in patients treated with percutaneous acetic acid injection alone and 12%, 24%, and 24% in patients treated with percutaneous acetic acid injection after transcatheter arterial embolization (P = NS)." | 2.68 | Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. ( Fujiwara, K; Ito, S; Ohnishi, K; Yoshioka, H, 1996) |
| "Hepatocellular carcinoma is the fifth most common cancer worldwide." | 2.49 | Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. ( Franke, A; Jakobsen, JC; Mössner, J; Schoppmeyer, K; Weis, S, 2013) |
| "Hepatocellular carcinoma is in 90% of cases associated with cirrhosis and to preserve liver function while destroying the tumor is a main issue in these patients justifying the development of local percutaneous ablative therapies." | 2.44 | Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments. ( Beaugrand, M; Seror, O, 2007) |
| "Worldwide, hepatocellular carcinoma (HCC) is a common, refractory, malignant tumor." | 2.43 | Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives. ( Huang, YH; Huo, TI; Wu, JC, 2005) |
| "Keywords were Hepatocellular carcinoma, liver metastases, percutaneous ethanol injection, cryotherapy, microwave coagulation therapy, radiofrequency ablation, interstitial laser photocoagulation, focused high-intensity ultrasound, hot saline injection, electrolysis and acetic acid injection." | 2.42 | The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. ( Aylott, C; Berry, DP; Garcea, G; Lloyd, TD; Maddern, G, 2003) |
| "The H22 mouse hepatoma ascites model was replicated, and were given 3-O-EZ and ingenol seven days (110." | 1.62 | The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC. ( Chen, PD; Ju, YH; Tang, YP; Wang, K; Wu, JH; Yao, WF; Zhang, L; Zhang, M; Zhang, Q; Zhang, Y, 2021) |
| "Despite the increasing incidence of hepatocellular carcinoma (HCC) worldwide, current pharmacological treatments are still unsatisfactory." | 1.62 | Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth. ( Altomare, A; Cavalluzzi, MM; Gnocchi, D; Lentini, G; Mangiatordi, GF; Mazzocca, A; Rizzi, R; Sabbà, C; Spennacchio, M; Tortorella, C, 2021) |
| "Among patients with treatment delay, disease progression was registered in 30 (63%) patients." | 1.34 | Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? ( Chi, CW; Chiang, JH; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Wu, JC, 2007) |
| "Thirty patients with 38 lesions of liver cancer were treated by the CT mediated intratumor injection of HAS6." | 1.33 | Destructive effect of percutaneous hydrochloric acid injection therapy for liver cancer--a preliminary experimental and clinical study. ( Hongmei, Z; Lei, Z; Ni, J; Suhong, H; Weijian, F; Yanjie, Z; Yi, C; Zan, L, 2006) |
| "The risk of disease progression in HCC patients stratified by tumor stage was mapped and equated with the risk of mortality of 456 cirrhotic patients without HCC." | 1.32 | Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. ( Chang, FY; Hou, MC; Huang, YH; Huo, TI; Lee, FY; Lee, PC; Lee, SD; Lin, HC; Wu, JC, 2004) |
| "Hepatic resection for huge hepatocellular carcinoma (HCC) is challenging." | 1.32 | Multimodality management of hepatocellular carcinoma larger than 10 cm. ( Chen, IS; Chen, YC; Chou, NH; Liang, HL; Liu, SI; Lo, GH; Mok, KT; Tsai, CC; Wang, BW; Yeh, MH, 2003) |
| "Preliminary study in a patient with hepatoma revealed focal signal at the injection site." | 1.31 | Chemical-shift MR imaging of acetic acid during percutaneous chemical ablation therapy: preliminary work. ( Clark, TW; Leigh, JS; Mondschein, J; Roberts, DA; Rosen, MA; Siegelman, E; Soulen, MC, 2002) |
| "Single high-dose PAI is safe and effective for treatment of small HCC." | 1.31 | Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment. ( Chen, CK; Cheng, JS; Lai, KH; Lai, PH; Liang, HL; Lo, GH; Pan, HB; Yang, CF, 2000) |
| "Two cases of liver metastasis from colon cancer were treated by percutaneous ethanol (PEI) and acetic acid (PAI) injection for the recurrent lesion after surgery." | 1.30 | [Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports]. ( Iguchi, Y; Sato, K; Shibata, N; Takesue, M; Tsunoda, T; Yamamoto, S, 1998) |
| "The human hepatoma cell line Hep G2 can be maintained in continuous culture and secretes numerous plasma proteins and lipoproteins into the medium." | 1.27 | Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2. ( Hagemenas, FC; Illingworth, DD; Lindsey, S, 1984) |
| "A 24h pretreatment of the human hepatoma cell line HepG2 with dibutyryl cyclic AMP in the presence of theophylline induced a dose dependent decrease in low density lipoprotein binding, uptake and degradation." | 1.27 | Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2. ( Auclair, M; Maziere, C; Maziere, JC; Mora, L; Moreau, M; Polonovski, J; Salmon, S, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.56) | 18.7374 |
| 1990's | 13 (18.06) | 18.2507 |
| 2000's | 39 (54.17) | 29.6817 |
| 2010's | 11 (15.28) | 24.3611 |
| 2020's | 5 (6.94) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, J | 1 |
| Chang, YJ | 2 |
| Chen, LJ | 1 |
| Chen, PD | 2 |
| Zhang, Q | 1 |
| Ju, YH | 1 |
| Zhang, Y | 1 |
| Wang, K | 1 |
| Zhang, M | 1 |
| Yao, WF | 1 |
| Tang, YP | 1 |
| Wu, JH | 1 |
| Zhang, L | 1 |
| Gnocchi, D | 1 |
| Cavalluzzi, MM | 1 |
| Mangiatordi, GF | 1 |
| Rizzi, R | 1 |
| Tortorella, C | 1 |
| Spennacchio, M | 1 |
| Lentini, G | 1 |
| Altomare, A | 1 |
| Sabbà, C | 1 |
| Mazzocca, A | 1 |
| Paul, SB | 1 |
| Acharya, SK | 1 |
| Gamanagatti, SR | 1 |
| Sreenivas, V | 1 |
| Shalimar, S | 1 |
| Gulati, MS | 1 |
| Weis, S | 3 |
| Franke, A | 2 |
| Mössner, J | 3 |
| Jakobsen, JC | 1 |
| Schoppmeyer, K | 3 |
| Berg, T | 1 |
| Fleig, WE | 2 |
| Gonella, S | 1 |
| Gonella, F | 1 |
| Kang, JH | 1 |
| Bruera, E | 1 |
| Cabral de Melo, FC | 1 |
| Borsato, D | 1 |
| de Macedo Júnior, FC | 1 |
| Mantovani, MS | 1 |
| Luiz, RC | 1 |
| Colabone-Celligoi, MA | 1 |
| Tsai, WL | 1 |
| Cheng, JS | 2 |
| Lai, KH | 2 |
| Lin, CP | 1 |
| Lo, GH | 3 |
| Hsu, PI | 1 |
| Yu, HC | 1 |
| Lin, CK | 1 |
| Chan, HH | 1 |
| Chen, WC | 1 |
| Chen, TA | 1 |
| Li, WL | 1 |
| Liang, HL | 3 |
| Kondo, T | 1 |
| Kishi, M | 1 |
| Fushimi, T | 1 |
| Kaga, T | 1 |
| Kolligs, FT | 1 |
| Hoffmann, RT | 1 |
| op den Winkel, M | 1 |
| Bruns, CJ | 1 |
| Herrmann, K | 1 |
| Jakobs, TF | 1 |
| Lamerz, R | 1 |
| Trumm, C | 1 |
| Zech, CJ | 1 |
| Wilkowski, R | 1 |
| Graeb, C | 1 |
| Forner, A | 1 |
| Bruix, J | 1 |
| Germani, G | 1 |
| Pleguezuelo, M | 1 |
| Gurusamy, K | 1 |
| Meyer, T | 1 |
| Isgrò, G | 1 |
| Burroughs, AK | 1 |
| Huo, TI | 10 |
| Hsu, CY | 1 |
| Huang, YH | 11 |
| Su, CW | 1 |
| Lin, HC | 2 |
| Lee, RC | 1 |
| Chiou, YY | 1 |
| Chiang, JH | 4 |
| Lee, PC | 10 |
| Lee, SD | 10 |
| Ma, H | 1 |
| Liu, J | 1 |
| Liu, F | 1 |
| Islam, MN | 1 |
| Azad, SA | 1 |
| Karim, E | 1 |
| Rahman, SM | 1 |
| Khan, NA | 1 |
| Roberts, DA | 1 |
| Rosen, MA | 1 |
| Clark, TW | 2 |
| Mondschein, J | 1 |
| Soulen, MC | 1 |
| Siegelman, E | 1 |
| Leigh, JS | 1 |
| Arrivé, L | 2 |
| Rosmorduc, O | 2 |
| Dahan, H | 1 |
| Fartoux, L | 2 |
| Monnier-Cholley, L | 1 |
| Lewin, M | 1 |
| Poupon, R | 2 |
| Tubiana, JM | 2 |
| Lau, WY | 2 |
| Leung, TW | 1 |
| Yu, SC | 1 |
| Ho, SK | 1 |
| Wu, JC | 10 |
| Chang, FY | 8 |
| Lin, SM | 3 |
| Lin, DY | 1 |
| Ke, WZ | 1 |
| Yu, DW | 1 |
| Gu, BP | 1 |
| Zhuang, ZW | 1 |
| MORI, K | 1 |
| EMMELOT, P | 1 |
| VAN VALS, GH | 1 |
| Garcea, G | 1 |
| Lloyd, TD | 1 |
| Aylott, C | 1 |
| Maddern, G | 1 |
| Berry, DP | 1 |
| Mok, KT | 1 |
| Wang, BW | 1 |
| Liu, SI | 1 |
| Chou, NH | 1 |
| Tsai, CC | 1 |
| Chen, IS | 1 |
| Yeh, MH | 1 |
| Chen, YC | 2 |
| Zuber-Jerger, I | 1 |
| Geissler, M | 1 |
| Spangenberg, HC | 1 |
| Mohr, L | 1 |
| Weizsäcker, F | 1 |
| Blum, HE | 1 |
| Huo, T | 1 |
| Lee, FY | 1 |
| Hou, MC | 1 |
| Park, JH | 1 |
| Oh, JH | 1 |
| Yoon, Y | 1 |
| Hong, SH | 1 |
| Park, SJ | 1 |
| Lin, CJ | 1 |
| Lin, CC | 1 |
| Hsu, CW | 1 |
| Andreani, T | 1 |
| Serfaty, L | 1 |
| Chazouillères, O | 1 |
| Arienti, V | 1 |
| Pretolani, S | 1 |
| Huang, HC | 1 |
| Lencioni, R | 1 |
| Della Pina, C | 1 |
| Crocetti, L | 1 |
| Cioni, D | 1 |
| Guan, YS | 1 |
| Liu, Y | 1 |
| Weijian, F | 1 |
| Zan, L | 1 |
| Suhong, H | 1 |
| Hongmei, Z | 1 |
| Lei, Z | 1 |
| Yanjie, Z | 1 |
| Yi, C | 1 |
| Ni, J | 1 |
| Chi, CW | 1 |
| Ho, CL | 1 |
| Chen, S | 1 |
| Yeung, DW | 1 |
| Cheng, TK | 1 |
| Garrean, S | 1 |
| Hering, J | 1 |
| Helton, WS | 1 |
| Espat, NJ | 1 |
| Beaugrand, M | 1 |
| Seror, O | 1 |
| Seki, T | 1 |
| Morimura, S | 1 |
| Tabata, S | 1 |
| Tang, Y | 1 |
| Shigematsu, T | 1 |
| Kida, K | 1 |
| Illingworth, DD | 1 |
| Lindsey, S | 1 |
| Hagemenas, FC | 1 |
| Ohnishi, K | 7 |
| Ohyama, N | 1 |
| Ito, S | 5 |
| Fujiwara, K | 5 |
| Parker, RA | 1 |
| Pearce, BC | 1 |
| Clark, RW | 1 |
| Gordon, DA | 1 |
| Wright, JJ | 1 |
| Gebhardt, R | 1 |
| Nomura, F | 1 |
| Yoshioka, H | 3 |
| Kosaka, K | 1 |
| Toshima, K | 1 |
| Nishiyama, J | 1 |
| Kameda, C | 1 |
| Peluso, MR | 1 |
| Dixon, JL | 1 |
| Fan, ST | 1 |
| Yamamoto, S | 1 |
| Iguchi, Y | 1 |
| Shibata, N | 1 |
| Takesue, M | 1 |
| Tsunoda, T | 1 |
| Sato, K | 1 |
| Hou, C | 1 |
| Chen, SC | 1 |
| Chang, WY | 1 |
| Chen, CH | 1 |
| Okada, S | 1 |
| Yang, CF | 1 |
| Pan, HB | 1 |
| Chen, CK | 1 |
| Lai, PH | 1 |
| Hargreaves, GM | 1 |
| Adam, R | 1 |
| Bismuth, H | 1 |
| Georgiades, CS | 1 |
| Ramsey, DE | 1 |
| Solomon, S | 1 |
| Geschwind, JF | 1 |
| Chao, A | 1 |
| Lai, CH | 1 |
| Hsueh, S | 1 |
| Chang, TC | 1 |
| Maziere, C | 1 |
| Maziere, JC | 1 |
| Salmon, S | 1 |
| Auclair, M | 1 |
| Mora, L | 1 |
| Moreau, M | 1 |
| Polonovski, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Radiofrequency Ablation Versus Laser Ablation for the Treatment of Small Hepatocellular Carcinoma: a Randomized Controlled Trial[NCT01096914] | 140 participants (Actual) | Interventional | 2009-01-31 | Completed | |||
| Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Small Hepatocellular Carcinoma：A Phase III, Prospective, Randomized, Open, Parallel Controlled Clinical Trial[NCT03898921] | Phase 3 | 270 participants (Anticipated) | Interventional | 2019-03-10 | Recruiting | ||
| Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for the Treatment of Recurrent Small Hepatocellular Carcinoma: a Prospective, Open, Randomized, Controlled Clinical Study[NCT04047173] | 166 participants (Anticipated) | Interventional | 2019-08-12 | Recruiting | |||
| A Phase I-II Study to Evaluate, in Patients Operated for a Hepatic Resection of Colorectal Liver Metastases, a High Intensity Focused Ultrasound (HIFU) Procedure: Feasibility, Safety and Accuracy.[NCT01489787] | 38 participants (Anticipated) | Interventional | 2010-03-31 | Recruiting | |||
| Feasibility of 11C-acetate in the Monitoring of Treatment Response Following Radiotherapy in Patients With Hepatocellular Carcinoma[NCT02549755] | Phase 2 | 1 participants (Actual) | Interventional | 2015-09-30 | Terminated (stopped due to Poor enrollment) | ||
| "A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. KYMES"[NCT01168700] | Phase 4 | 46 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for acetic acid and Liver Neoplasms
| Article | Year |
|---|---|
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Hepat | 2013 |
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Topics: Acetic Acid; Administration, Cutaneous; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cat | 2015 |
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Topics: Acetic Acid; Administration, Cutaneous; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cat | 2009 |
[Diagnosis and multimodal therapy for hepatocellular carcinoma].
Topics: Acetic Acid; Antineoplastic Agents; Brachytherapy; Carcinoma, Hepatocellular; Catheter Ablation; Che | 2010 |
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Human | 2010 |
Interventional radiology for the treatment of hepatic malignancy.
Topics: Acetic Acid; Brachytherapy; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality The | 2012 |
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications; | 2003 |
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications; | 2003 |
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications; | 2003 |
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Contraindications; | 2003 |
Percutaneous local ablation therapy in small hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Electrocoagulation; Ethanol; Humans; Inje | 2003 |
The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Cryotherapy; Electrolysis; Ethanol; Human | 2003 |
[Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods].
Topics: Acetic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Catheter Abla | 2004 |
Percutaneous ablation therapy for hepatocellular carcinoma: current practice and future perspectives.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Indicators and Reagents; | 2005 |
Percutaneous ablation of hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Clinical Trials as Topic; Ethanol; Humans | 2006 |
Interventional treatments for hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cryosurge | 2006 |
A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors.
Topics: Acetic Acid; Antineoplastic Agents; Catheter Ablation; Cryosurgery; Embolization, Therapeutic; Ethan | 2007 |
Chemical ablation of liver cancer.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona | 2007 |
Transcutaneous treatments of hepatocellular carcinoma in patients with cirrhosis: present status and future developments.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Ethanol; Human | 2007 |
Local ablation therapy for hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona | 1999 |
Results after nonsurgical local treatment of primary liver malignancies.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Cryosurgery; Embolization, Therapeutic; Ethanol; Humans; Hyp | 2000 |
New nonsurgical therapies in the treatment of hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Infusions, Intra-Arteria | 2001 |
[Percutaneous acetic acid injection therapy].
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Clinical Trials as Topic; Combined Modali | 2001 |
12 trials available for acetic acid and Liver Neoplasms
| Article | Year |
|---|---|
Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial.
Topics: Acetic Acid; Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Middle A | 2020 |
Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug | 2003 |
Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study.
Topics: Acetic Acid; Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chem | 2003 |
Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeut | 2004 |
Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemo | 2004 |
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Female; H | 2005 |
Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Feasi | 2005 |
Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid.
Topics: Acetates; Acetic Acid; Aged; Animals; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization, | 1994 |
Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases.
Topics: Acetates; Acetic Acid; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Bi | 1996 |
Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection.
Topics: Acetic Acid; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Follow-Up Studies; | 1996 |
Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Ethanol; Female; Humans; In | 1998 |
Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Ethanol; Female; Humans; In | 1998 |
40 other studies available for acetic acid and Liver Neoplasms
| Article | Year |
|---|---|
Drinking vinegar, a potential adjuvant for immunotherapy of HCC?
Topics: Acetic Acid; Adjuvants, Immunologic; Carcinoma, Hepatocellular; Humans; Immunotherapy; Liver Neoplas | 2023 |
Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
Topics: Ablation Techniques; Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Disease | 2020 |
The water expelling effect evaluation of 3-O-(2'E,4'Z-decadienoyl)-20-O-acetylingenol and ingenol on H22 mouse hepatoma ascites model and their content differences analysis in Euphorbia kansui before and after stir-fried with vinegar by UPLC.
Topics: Acetic Acid; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Aquaporin 2; Aquaporins; Ascites | 2021 |
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth.
Topics: Acetic Acid; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Dose- | 2021 |
Use of vinegar to relieve persistent hiccups in an advanced cancer patient.
Topics: Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Hiccup | 2015 |
Hiccups during Chemotherapy: What Should We Do?
Topics: Acetic Acid; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Hiccup; Humans; Live | 2015 |
Study of levan productivity from Bacillus subtilis Natto by surface response methodology and its antitumor activity against HepG2 cells using metabolomic approach.
Topics: Acetic Acid; Alanine; Antineoplastic Agents; Bacillus subtilis; Energy Metabolism; Fermentation; Fru | 2015 |
Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
Topics: Acetic Acid; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ethano | 2008 |
Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation.
Topics: Acetic Acid; Acetyl-CoA Carboxylase; Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Fa | 2009 |
Ablation for hepatocellular carcinoma: Is there need to have a winning technique?
Topics: Acetic Acid; Administration, Cutaneous; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Human | 2010 |
Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Catheter | 2010 |
CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Humans; Inje | 2012 |
Chemical-shift MR imaging of acetic acid during percutaneous chemical ablation therapy: preliminary work.
Topics: Acetic Acid; Animals; Carcinoma, Hepatocellular; Cattle; Contrast Media; Gadolinium; Humans; Injecti | 2002 |
Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluo | 2003 |
[Raman spectroscopic study of microscopic damage on the space structure of DNA with acetic acid].
Topics: Acetic Acid; Animals; Chemoembolization, Therapeutic; DNA Damage; Fishes; Humans; Liver Neoplasms; N | 2001 |
Inhibition of experimental production of liver cancer by addition of acetic acid to the diet.
Topics: Acetates; Acetic Acid; Animals; Bile Duct Neoplasms; Carcinogens; Diet; Liver Neoplasms; Neoplasms, | 1953 |
The metabolism of neoplastic tissues; the metabolic activity of normal and cancerous rat livers studied with acetate-1-14C invitro.
Topics: Acetates; Acetic Acid; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Liver Neoplasms; Rats | 1957 |
Multimodality management of hepatocellular carcinoma larger than 10 cm.
Topics: Acetic Acid; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2003 |
Persistent retention of acetic acid is associated with complete tumour necrosis in patients with hepatocellular carcinoma undergoing percutaneous acetic acid injection.
Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Female; Humans; Injections, | 2004 |
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiency.
Topics: Acetic Acid; Aged; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; Creatinine; Ethanol; F | 2004 |
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
Topics: Acetic Acid; Administration, Cutaneous; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeu | 2004 |
Acetic acid sclerotherapy for treatment of a biliary leak from an isolated bile duct after hepatic surgery.
Topics: Acetic Acid; Bile Duct Diseases; Bile Ducts; Cystadenocarcinoma; Female; Hepatectomy; Humans; Liver | 2005 |
Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Catheter Ablation; Ethanol; Humans; Injections, Intralesiona | 2006 |
Fever and infectious complications after percutaneous acetic acid injection therapy for hepatocellular carcinoma: incidence and risk factor analysis.
Topics: Abscess; Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Carcinoma, Hepatocellu | 2006 |
Destructive effect of percutaneous hydrochloric acid injection therapy for liver cancer--a preliminary experimental and clinical study.
Topics: Acetic Acid; Animals; Cell Line, Tumor; Ethanol; Gastric Juice; Humans; Hydrochloric Acid; In Vitro | 2006 |
Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
Topics: Acetic Acid; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Progression; E | 2007 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carci | 2007 |
Antioxidant activity of vinegar produced from distilled residues of the Japanese liquor shochu.
Topics: Acetic Acid; Alcoholic Beverages; Animals; Antioxidants; Carbon Tetrachloride; Carcinoma, Hepatocell | 2008 |
Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2.
Topics: Acetates; Acetic Acid; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Humans; Kinetics; Lipoprot | 1984 |
Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Topics: Acetates; Acetic Acid; Androstenes; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell L | 1993 |
Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes.
Topics: Acetates; Acetic Acid; Animals; Anticholesteremic Agents; Carcinoma, Hepatocellular; Cells, Cultured | 1993 |
Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization.
Topics: Acetic Acid; Aged; Angiography; Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fema | 1996 |
Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetic Acid; Apolipoprotein B-100; Apolipoproteins B; beta-Cyclod | 1997 |
Can small hepatocellular carcinoma be cured by percutaneous acetic acid injection therapy?
Topics: Acetic Acid; Carcinoma, Hepatocellular; Humans; Injections, Intralesional; Liver Neoplasms; Ultrason | 1997 |
[Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports].
Topics: Acetic Acid; Carcinoembryonic Antigen; Colon, Sigmoid; Colonic Neoplasms; Ethanol; Female; Hepatecto | 1998 |
Comparison of necrotic characteristics and benefits between 50% acetic acid and pure ethanol in local hepatic injection: a study in rats.
Topics: Acetic Acid; Animals; Ethanol; Liver; Liver Neoplasms; Male; Necrosis; Rats; Rats, Sprague-Dawley | 1999 |
Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Dose-Response Relationship, | 2000 |
Local ablative therapy for hepatocellular carcinoma.
Topics: Acetic Acid; Carcinoma, Hepatocellular; Ethanol; Humans; Hyperthermia, Induced; Injections, Intrales | 2000 |
Intralesional injection for hepatic metastasis from cervical carcinoma. A report of two cases.
Topics: Acetic Acid; Aged; Carcinoma; Ethanol; Female; Humans; Indicators and Reagents; Injections, Intrales | 2001 |
Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2.
Topics: Acetates; Acetic Acid; Bucladesine; Carcinoma, Hepatocellular; Cell Line; Cholesterol; Cyclic AMP; H | 1988 |